Internal Medicine, Pulmonary Disease · Northampton, MA
NPI
1114904497
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
141 King St
Northampton, MA, 01060
Phone (413) 570-9505
Groups this clinician bills Medicare through
Medicare paid, 2024
$55K
623 services
Medicare patients, 2024
289
Average age 73
Drug cost, 2024
$1.8M
2,203 prescriptions
Company payments, 2025
$1,607
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jay S Fleitman was code 99214 (office e&m - established), 420 times for 223 patients. In total Jay S Fleitman billed 623 services in 14 codes, and Medicare paid $55K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 420 | 223 | $92.28 | $39K |
| 99204 Office E&M - New | Office | 79 | 79 | $116.39 | $9,195 |
| 95806 Sleep Study | Office | 44 | 44 | $65.53 | $2,883 |
| 99443 Telephone Services | Office | 34 | 26 | $91.00 | $3,094 |
| 99213 Office E&M - Established | Office | 12 | 12 | $60.34 | $724 |
By year: 2022 $109K for 1,247 services; 2023 $69K for 743 services; 2024 $55K for 623 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jay S Fleitman prescribed most often to Medicare patients was Zafirlukast, with 236 prescriptions and refills. In total Jay S Fleitman wrote 2,203 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Zafirlukast Generic | 236 | 574 | 66 | $29K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 220 | 429 | 65 | $263K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 174 | 223 | 59 | $7,641 |
| Fluticasone Propionate Generic | 111 | 267 | 47 | $2,200 |
| Combivent Respimat Ipratropium/Albuterol Sulfate | 91 | 158 | 20 | $91K |
| Prednisone Generic | 79 | 107 | 30 | $553 |
| Gabapentin Generic | 75 | 125 | 19 | $1,721 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 70 | 142 | 22 | $86K |
| Ventolin Hfa Albuterol Sulfate | 69 | 104 | 24 | $7,555 |
| Arnuity Ellipta Fluticasone Furoate | 63 | 135 | 23 | $33K |
| Ipratropium Bromide Generic | 58 | 115 | 23 | $2,359 |
| Omeprazole Generic | 55 | 137 | 18 | $1,064 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 53 | 89 | 15 | $40K |
| Modafinil Generic | 53 | 131 | 16 | $4,682 |
| Dupixent Pen Dupilumab | 49 | 49 | Under 11 | $208K |
Brand drugs: 1,128 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jay S Fleitman $1,607 ($1,607 in general payments such as food, travel and fees) from 18 companies. The largest payer was GlaxoSmithKline, LLC. with $336.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 20 | $336 |
| E.R. Squibb & Sons, L.L.C. BMY | 18 | $292 |
| Actelion Pharmaceuticals US, Inc. JNJ | 6 | $200 |
| Harmony Biosciences LLC HRMY | 6 | $171 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $111 |
| Alnylam Pharmaceuticals Inc. ALNY | 4 | $104 |
| Axsome Therapeutics, Inc. AXSM | 3 | $78.73 |
| Amgen Inc. AMGN | 4 | $60.34 |
| Azurity Pharmaceuticals, Inc. | 2 | $43.7 |
| Genzyme Corporation SNY | 2 | $37.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.